Ponvory
My Prescription
Payment
Select pharmacy
$11,319.87
Print or send this coupon to your phone
WalgreensPowered byAbout Ponvory
Drug Details
Ponvory (ponesimod) is an oral medication prescribed for adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. This medication works by modulating the sphingosine 1-phosphate receptors, which may help reduce the number of lymphocytes—white blood cells—entering the central nervous system. By doing so, it helps decrease inflammation and potential damage in the brain and spinal cord. Although Ponvory is not a cure for MS, it can reduce the frequency of relapses and may slow down the progression of disability associated with the disease. When starting Ponvory, patients will follow a specific dosing regimen beginning with a starter pack before transitioning to a maintenance dose. Regular monitoring, including lab tests or exams, is recommended due to potential side effects affecting the heart, liver, and eyes. As Ponvory is only available as a brand-name drug, it might be costly. Always consult with a healthcare provider before starting any new medication to ensure it is safe and appropriate for your condition.
Price history for Ponvory
30 Tablets, 20MG
Average retail price for Ponvory
Average SaveHealth price for Ponvory
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Ponvory dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 20MG | 30 Tablets | $11,411.19 | $380.37 |
Ponvory FAQs
Ponvory is used for the treatment of relapsing forms of multiple sclerosis (MS) in adults. This includes clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Ponvory (ponesimod) is a medication used to treat relapsing forms of multiple sclerosis. In clinical trials, Ponvory demonstrated a significant reduction in annualized relapse rates compared to a placebo. Specifically, it showed a 30.5% reduction in relapses over a two-year period. Additionally, Ponvory was effective in reducing the number of new or enlarging brain lesions. However, individual responses to the medication can vary, and it is important for patients to discuss their specific situation and treatment goals with their healthcare provider.
The cost of Ponvory can vary depending on factors such as the pharmacy, location, insurance coverage, and any available discounts or patient assistance programs. It is recommended to contact a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may inquire about financial assistance programs offered by the manufacturer or other organizations.
Yes, Ponvory (ponesimod) is considered an immunosuppressant. It works by modulating the immune system to reduce the frequency of relapses in individuals with multiple sclerosis.
The effectiveness of Ponvory (ponesimod) compared to teriflunomide can vary depending on the individual patient's condition and response to treatment. Ponvory is a newer medication for multiple sclerosis and has shown in clinical trials to have a higher efficacy in reducing annualized relapse rates compared to teriflunomide. However, the choice between these medications should be based on a comprehensive evaluation by a healthcare provider, considering factors such as side effects, patient preference, and specific health conditions. It is important for patients to discuss with their healthcare provider to determine the most appropriate treatment for their situation.